| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 07/01/2004 | WO2004054584A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists |
| 07/01/2004 | WO2004054581A2 Cyclohexyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004054498A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 07/01/2004 | WO2004031145A3 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 07/01/2004 | WO2004017911A3 Protease inhibitors |
| 07/01/2004 | WO2004016086B1 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 07/01/2004 | WO2004013093A3 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 07/01/2004 | WO2003093297A3 Protein kinase modulators and methods of use |
| 07/01/2004 | WO2003080577A3 Amidoacetonitrile compounds |
| 07/01/2004 | US20040127733 adrenergic blocking agents; for treatment of diabetes/obesity |
| 07/01/2004 | US20040127722 such as 5,11,17,23-tetraiodo-25,26,27,28-tetrahydroxythiacalix[4]arene; for manufacturing materials having optical limiter properties/protection against lasers |
| 07/01/2004 | US20040127713 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs |
| 07/01/2004 | US20040127708 antiviral activities; aids treatment |
| 07/01/2004 | US20040127707 Novel phthalazinones |
| 07/01/2004 | US20040127658 Productivity catalysts and microstructure control |
| 07/01/2004 | US20040127592 Mono-, oligo- and poly(3-alkynylthiophenes) and their use as charge transport materials |
| 07/01/2004 | US20040127549 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |
| 07/01/2004 | US20040127536 Indazole Derivatives |
| 07/01/2004 | US20040127528 Metalloproteinase inhibitors |
| 07/01/2004 | US20040127527 Large conductance calcium-activated k channel opener |
| 07/01/2004 | US20040127518 For therapy of anxiety or pain, and other neurological, sleep, or psychological disorders, for inducing sleep, for treating glaucoma, and controlling appetite or appetive disorders |
| 07/01/2004 | US20040127517 For therapy of treat atherosclerosis, autoimmune diseases, multiple sclerosis), asthma, rheumatoid arthritis, fibrotic diseases, idiopathic pulmonary fibrosis, cystic fibrosis, glumerulonephritis, rheumatoid spondylitis, osteoarthritis, gout |
| 07/01/2004 | US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 07/01/2004 | US20040127510 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 07/01/2004 | US20040127507 Imidazolidine compounds |
| 07/01/2004 | US20040127502 Use of pyrimidine compound galanin receptor subtype 3 (GAL3) antagonists, which may be classified as neutral antagonists, inverse agonists or allosteric modulators, to treat depressive disorders and/or anxiety |
| 07/01/2004 | US20040127482 Substituted heterocycle fused gamma-carbolines |
| 07/01/2004 | US20040127477 Heterocyclic glycyl beta-alanine derivatives |
| 07/01/2004 | US20040127469 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/01/2004 | DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments |
| 07/01/2004 | DE10259933A1 Substituierte 4-Aryl-Pyridine 4-aryl-substituted pyridines |
| 07/01/2004 | DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
| 07/01/2004 | DE10257539A1 Verfahren zur Herstellung von 2,2'-Di(3,4-ethylendioxythiophen)en A process for preparing 2,2'-di (3,4-ethylenedioxythiophene) s |
| 07/01/2004 | CA2549463A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |
| 07/01/2004 | CA2509244A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | CA2509239A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | CA2509233A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | CA2508045A1 Novel compounds having selective inhibiting efect at gsk3 |
| 07/01/2004 | CA2507629A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 07/01/2004 | CA2507425A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists |
| 06/30/2004 | EP1433788A1 Pyrazole-derivatives as factor Xa inhibitors |
| 06/30/2004 | EP1433781A1 Pyrrolidine carboxylic acid derivatives |
| 06/30/2004 | EP1433779A1 Use of nitriles as inhibitors of non-proteolytic enzymes |
| 06/30/2004 | EP1433778A1 Use of nitriles as rotamase inhibitors |
| 06/30/2004 | EP1433479A1 Appetite-stimulating agents and remedies for anorexia |
| 06/30/2004 | EP1432706A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 06/30/2004 | EP1432702A1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 06/30/2004 | EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 06/30/2004 | EP1432698A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 06/30/2004 | EP1432696A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 06/30/2004 | EP1432693A2 Mch receptor antagonists |
| 06/30/2004 | EP1432691A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 06/30/2004 | EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 06/30/2004 | EP1432689A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 06/30/2004 | EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 06/30/2004 | EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/30/2004 | EP1432415A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 06/30/2004 | EP1432313A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
| 06/30/2004 | EP1037880B1 Retinoic acid mimetic anilides |
| 06/30/2004 | EP0746555B1 High temperature epoxy resins |
| 06/30/2004 | CN1509286A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509282A 4-(phenyl-piperdin-4-ylidene-methyl)benzamide derivatives and theive use for treating pain, anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509276A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509275A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509272A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1155589C Compounds and methods for modulation of estroglen receptors |
| 06/30/2004 | CN1155574C Ether muscarinic antagonists |
| 06/30/2004 | CN1155572C Indole derivatives and its anticancer usage |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756388 Having piperidinyl and phenolic functionality; bone loss; breast or prostate cancer |
| 06/29/2004 | US6756387 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 06/29/2004 | US6756370 Piperidine alcohols |
| 06/29/2004 | US6756354 Stabilization of drugs |
| 06/29/2004 | US6756342 Substituted thienocycloalk(en) ylamino -1,3,5-triazine |
| 06/29/2004 | CA2178604C Novel imidazole derivative and process for producing the same |
| 06/24/2004 | WO2004052995A1 Process for the production of meso-substituted cyanine dyes |
| 06/24/2004 | WO2004052890A1 Heterocyclic compounds, methods of making them and their use in therapy |
| 06/24/2004 | WO2004052885A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 06/24/2004 | WO2004052884A1 Anthranilic acid amide derivatives and their pharmaceutical use |
| 06/24/2004 | WO2004052879A1 Thiophenederivatives for the treatment of flavivirus infections |
| 06/24/2004 | WO2004052878A2 Crystalline derivative of 2- (5-chlorothien-2-yl)-n- ((3s)-1((1s)-1-methyl-2-morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl) ethensulfonamide |
| 06/24/2004 | WO2004052876A1 Substituted 4-phenyl-[1,3]-dioxanes |
| 06/24/2004 | WO2004052869A1 5-substituted-pyrazine or pyridine glucokinase activators |
| 06/24/2004 | WO2004052864A1 Pyrazole and imidazole compounds and uses thereof |
| 06/24/2004 | WO2004052857A1 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| 06/24/2004 | WO2004052855A2 Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052853A2 Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052851A1 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052366A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 06/24/2004 | WO2004024060A3 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 06/24/2004 | WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122239 via dehydrogenation; for production of semiconductor polymers/light emitting diodes |
| 06/24/2004 | US20040122237 Substituted benzazoles and methods of their use as inhibitors of Raf kinase |
| 06/24/2004 | US20040122234 Growth Hormone secretagogues |